Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
Matias Autio, Suvi‐Katri Leivonen, Oscar Brück, et al.
Haematologica (2020) Vol. 106, Iss. 3, pp. 718-729
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
Nathalie Scholler, Régis Perbost, Frederick L. Locke, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1872-1882
Open Access | Times Cited: 128
Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment
Yang Chen, Keren Jia, Yu Sun, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 117
The Immunology of DLBCL
Taishi Takahara, Shigeo Nakamura, Toyonori Tsuzuki, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 835-835
Open Access | Times Cited: 33
Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma
Min Liu, Giorgio Bertolazzi, Shruti Sridhar, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma
Michael Beck, Viktoria Blumenberg, Veit Bücklein, et al.
EJNMMI Research (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma
Zijun Y. Xu‐Monette, Wei Li, Xiaosheng Fang, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 5, pp. 972-983
Open Access | Times Cited: 36
Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response
Miao‐Zhen Qiu, Chaoye Wang, Zhi‐Ying Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 20
Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging
Kyle Wright, Jason L. Weirather, Sizun Jiang, et al.
Blood Advances (2023) Vol. 7, Iss. 16, pp. 4633-4646
Open Access | Times Cited: 17
Diffuse large B-cell lymphoma: the significance of CD8+ tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway
Qiqi Zhu, Yiming Yang, Kexin Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma
Xiaoran Bai, Fei Lu, Shuying Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial
Carlos Jiménez‐Cortegana, Natalia Palazón‐Carrión, Alejandro Martı́n, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 6, pp. e002323-e002323
Open Access | Times Cited: 40
Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment
Matias Autio, Suvi‐Katri Leivonen, Oscar Brück, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 4, pp. 781-792
Open Access | Times Cited: 33
Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma
Tiantian Yu, Zijun Y. Xu‐Monette, Anand S. Lagoo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
The transition between M1 and M2 macrophage phenotypes is associated with the disease status following CD19 CAR-T therapy for B cell lymphoma/leukemia
Li Zhao, Fen Yan, Donghai Tang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironment
Xiaoli Lou, Ke Zhao, Jingze Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-12
Closed Access
Identification of intratumoral microbiome-driven immune modulation and therapeutic implications in diffuse large B-cell lymphoma
Zheng Yijia, Xiaoyu Li, Li‐Na Ma, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Prognostic significance of CD8 + tumor-infiltrating lymphocytes in operable breast cancer: a meta-analysis
Ruijie Niu, Cheng Wang, Yiqun Xie, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Proteome alterations in peripheral immune cells of DLBCL patients and evidence of cancer extracellular vesicles involvement
Mostafa Ejtehadifar, Sara Zahedi, Paula Gameiro, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167842-167842
Open Access
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
Heli Vajavaara, Julie Bondgaard Mortensen, Suvi‐Katri Leivonen, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 398-398
Open Access | Times Cited: 24
Testicular Diffuse Large B-Cell Lymphoma—Clinical, Molecular, and Immunological Features
Marjukka Pollari, Suvi‐Katri Leivonen, Sirpa Leppä
Cancers (2021) Vol. 13, Iss. 16, pp. 4049-4049
Open Access | Times Cited: 24
Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies
Kamira Maharaj, Angimar Uriepero, Eva Sahakian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Novel insights into Hodgkin lymphoma biology by single-cell analysis
Tomohiro Aoki, Christian Steidl
Blood (2022) Vol. 141, Iss. 15, pp. 1791-1801
Open Access | Times Cited: 17
Immunity and Extracellular Matrix Characteristics of Breast Cancer Subtypes Based on Identification by T Helper Cells Profiling
Yan Zhou, Qi Tian, Huan Gao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
The prognostic value of tumor-associated macrophages detected by immunostaining in diffuse large B cell lymphoma: A meta-analysis
Mei Lin, Shupei Ma, Lingling Sun, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top